Stressful experiences affect the course of co-occurring obsessive-compulsive and psychotic symptoms: A focus on within-subject processes
Schirmbeck, F., Konijn, M., Hoetjes, V., Vermeulen, J.M.D., Zink, M.,
Dekker, J.J.M. &
De Haan, L.Verschenen in Schizophrenia Research, 216, 69-76 (2020)
Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
Berendsen, S.,
Van, H., van der Paardt, J.W., de Peuter, O.R., van Bruggen, M., Nusselder, H., Jalink, M.,
Peen, J.,
Dekker, J.J.M. &
De Haan, L.Verschenen in Early Intervention in Psychiatry, Volume 15, issue 3, 669-675 (2020)
The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders
Berendsen, S., van Tricht, M.J., Tedja, A.,
Burger, T.,
De Koning, M.B. &
De Haan, L.Verschenen in International Journal of Methods in Psychiatric Research, Volume 30, Issue 2, 1-8 (2020)
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project
Berendsen, S., Kapitein, P.,
Schirmbeck, F., van Tricht, M.J., Mcguire, P., Morgen, C.,
De Haan, L. & et al.
Verschenen in Schizophrenia Research, Volume 230, 104-107 (2020)
Burying Our Heads in the Sand: The Neglected Importance of Reporting Inter-Rater Reliability in Antipsychotic Medication Trials
Berendsen, S.,
Van, H., Verdegaal, L.M.A., van Tricht, M.J.,
Blankers, M. &
De Haan, L.Verschenen in Schizophrenia Bulletin, Vol. 46 no. 5, 1027-1029 (2020)
But I did not touch nobody!-Patients’ and nurses’ perspectives and recommendations after aggression on psychiatric wards-A qualitative study
Vermeulen, J.M., Doedens, P.R.M., Boyette, L.N.J., Spek, B., Latour, C.H.M.R.N. &
De Haan, L.Verschenen in Journal of Advanced Nursing , Volume75, Issue11, 2845-2854 (2019)
Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition
Mansueto, G., Schruers, K., Cosci, F.,
De Haan, L.,
Schirmbeck, F., GROUP Investigators & van Os, J.
Verschenen in Schizophrenia Research, Volume 206, 183-193 (2019)
Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial
Pos, K., Franke, N., Smit, F., Wijnen, B.F.M., Staring, A.B.P., van der Gaag, M., Meijer, C.,
De Haan, L., Velthorst, E. &
Schirmbeck, F.Verschenen in Journal of Consulting and Clinical Psychology, 87 (2), 151–160 (2019)
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
Cakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P.J.,
De Haan, L., Bahn, S., Penninx, B.W.J.H. & van Beveren, N.J.M.
Verschenen in European Neuropsychopharmacology, Volume 29, Issue 7, 835-846 (2019)
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
Alqarni, A., Todd, W.M., McGorry, P.D., Nelson, B., Markulevm C., Yuen, H.P., Schäfer, M.R.,
De Haan, L., Meyera, B.J. & et. al.
Verschenen in Schizophrenia Research, Volume 226, 44-51 (2019)
Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis
Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J.,
De Haan, L., Pijnenborg, G.H.M. & et al.
Verschenen in Frontiers in Psychiatry, 10, 345 (2019)
Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis
Wijnen, B.F.M., Thielen, F.W., Konings, S., Feenstra, T., van der Gaag, M., Veling, W.,
De Haan, L., Ising, H., Hiligsman, M., Evers, S.M.A.A., Smit, F. & Lokkerbol, J.
Verschenen in Expert Review of Pharmacoeconomics & Outcomes Research, Volume 20, 2020, Issue 3, 269-279 (2019)
Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study
Vermeulen, J.M., Wootton, R.E., Treur, J.L., Sallis, H.M., Jones, H.J., Zammit, S., van den Brink, W., Goodwin, G.M.,
De Haan, L. & Munafo, M.R.
Verschenen in The British Journal of Psychiatry, Volume 218 , Issue 2, 88 - 94 (2019)
Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis
Sutterland, A.L., Kuin, A., Kuiper, B., van Gool, T., Leboyer, M., Fond, G. &
De Haan, L.Verschenen in Psychological Medicine, Volume 49, Issue 10 , 1608-1623 (2019)
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
van Rooijen, G., van Rooijen, M., Maat, A., Vermeulen, J.M., Meijer, C.J., Ruhé, H.G.,
De Haan, L. & GROUP Investigators
Verschenen in Schizophrenia Researh, 208, 82-89 (2019)
Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study
Vermeulen, J.M.D.,
Schirmbeck, F.,
Blankers, M., van Tricht, M.J., van den Brink, W. &
De Haan, L.Verschenen in The Lancet Psychiatry, 6, 1, 25-34 (2019)
Dying too soon: Excess mortality in Severe Mental Illness
De Mooij, L.D.,
Kikkert, M.J., Theunissen, J.,
Beekman, A.T.F.,
De Haan, L.,
Duurkoop, P.W.R.A.,
Van, H. &
Dekker, J.J.M.Verschenen in Frontiers in Psychiatry, Volume 10, 1-10 (2019)
Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis
Vermeulen, J.M., van Rooijen, G., van Tricht, M.J., van Dijk, M. &
De Haan, L.Verschenen in Journal of Mental Health, Volume 30, Issue 5, 564-570 (2019)
Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels
Schirmbeck, F., Konijn, M., Hoetjes, V., Zink, M. &
De Haan, L.Verschenen in European Archives of Psychiatry and Clinical Neuroscience, 269, 245-255 (2019)
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
Guloksuz, S., Pries, L.K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D.,
De Haan, L., GROUP Researchers & van Os, J.
Verschenen in World Psychiatry, 18(2), 173-182 (2019)
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study
Menghini-Müller, S., Studerus, E., Ittig, S., Heitz, U., Egloff, L., Andreou, C., Valmaggia, L.R., Kempton, M.J., van der Gaag, M.,
De Haan, L. & et al.
Verschenen in European Psychiatry, 59, 52-59 (2019)
Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients
van der Pluijm, M., Sutterland, A.L., van Kullenbrog, A.B.P., Zoetekouw, L.,
De Haan, L., Booij, J. & van de Giessen, E.
Verschenen in Therapeutic Advances in Psychopharmacology, 9, 1-7 (2019)
